MolecuLight Presents Cutting-Edge Wound Care Imaging at CAMPS 2025 Summit
MolecuLight Showcases Advanced Wound Care Imaging at CAMPS 2025
MolecuLight Corp., known as a pioneer in point-of-care fluorescence imaging for wound care, proudly announces its involvement in the 2025 Cellular, Acellular, and Matrix-like Products (CAMPs) Wound Care Summit, scheduled for February 28th to March 2nd in Fort Lauderdale, Florida. This event will be an ideal opportunity for healthcare professionals to explore how MolecuLight's groundbreaking technology can significantly improve the process of wound assessment, documentation, and treatment decision-making related to CAMPs, especially with the upcoming changes to local coverage determination guidelines concerning skin substitutes.
Advanced Technology in Action
During the summit, attendees will be able to visit MolecuLight's booth (#21), where they can witness the device's capabilities firsthand and engage in discussions about its practical applications throughout the wound care continuum. MolecuLight's fluorescence imaging is designed to assist clinicians in quickly identifying harmful bacterial loads associated with infection, which are often a precursor to CAMPs failure. This instant visual insight empowers healthcare providers to make informed decisions, leading to quicker wound closures and improved patient outcomes.
The Importance of Real-Time Data
With real-time visualization of bacterial presence, clinicians can enhance targeted therapies, such as preparing the wound bed for CAMPs. The immediate feedback offered by MolecuLight supports healthcare strategies aimed at optimizing wound management based on actionable data. Anil Amlani, CEO of MolecuLight, highlighted the pressing need for this technology in the field of wound care, stating, "By visualizing bacterial presence, we can help support the efficacy of advanced therapies such as CAMPs, improve patient outcomes, and ultimately reduce the burden of chronic wounds."
Meeting Evolving Standards
The proposed new local coverage determination language for skin substitutes underscores the necessity for comprehensive wound assessment and documentation. MolecuLight addresses these requirements with its devices, which provide:
- - Objective, visual evidence of wound conditions,
- - Automated and accurate wound measurements, and
- - Enhanced documentation to support the medical necessity of advanced therapies.
"MolecuLight's ability to provide real-time, objective data aligns perfectly with the evolving standards for wound care documentation and treatment," added Amlani. "We are eager to demonstrate how our technology can empower healthcare providers to fulfill the requirements of the proposed LCD language, resulting in optimal patient care."
Engage at the CAMPS Meeting
Attendees at the 2025 CAMPS Meeting are encouraged to visit MolecuLight at their designated booth to experience the benefits of their innovative technology. Furthermore, they can attend the breakout session entitled, How to ensure optimal outcomes with CAMPs, scheduled for February 28th from 11:25 AM to 12:45 PM. This session will highlight how MolecuLight's technology can facilitate improved wound bed preparation, leading to better outcomes with CAMPs.
About MolecuLight
Founded as a privately held medical imaging enterprise, MolecuLight works tirelessly to manufacture and commercialize devices such as the MolecuLight iX® and DX™. These devices are recognized as the only FDA-cleared point-of-care imaging solutions specifically designed to detect elevated bacterial burdens in real-time while also offering precise digital wound measurements. Backed by substantial clinical evidence, including over 100 peer-reviewed studies, MolecuLight continues to lead advancements in comprehensive wound management.
For inquiries regarding sales, media, or more information, please contact:
Hunter Zudans
Director of Marketing
MolecuLight Inc.
T. +1.484.682.7580
Email: info@moleculight.com
Website: us.moleculight.com
This revolutionary technology not only promises to enhance patient care but also sets a new precedent for the future of wound management.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.